First experience with model-based selection of head and neck cancer patients for proton therapy

Langendijk, 2013, Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach, Radiother Oncol, 107, 267, 10.1016/j.radonc.2013.05.007 Landelijk Platform Protonentherapie (LPPT). Landelijk Indicatieprotocol Protonentherapie Hoofdhals 2017. http://www.nvro.nl/publicaties/rapporten.html. Nation-wide incidence of Head and Neck Cancers 2019. https://www.cijfersoverkanker.nl/selecties/Dataset_2/img5ca32fcf8c644. CVZ. Protonentherapie bij model-based indicaties (hoofdhalstumoren, mammacarcinoom, longcarcinoom en prostaatcarcinoom) en bij overige indicaties. 304 2011. https://www.zorginstituutnederland.nl/publicaties/standpunten/2011/08/22/protonentherapie-indicaties-voor-protonentherapie-deel-2---model-based-indicaties-hoofd-halstumoren-mammacarcinoom-longcarcinoom-en-prostaatcarcinoom. Kierkels, 2016, Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2–4 dysphagia and tube feeding dependence in head and neck radiotherapy, Radiother Oncol, 121, 374, 10.1016/j.radonc.2016.08.016 Brouwer, 2015, CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines, Radiother Oncol, 117, 83, 10.1016/j.radonc.2015.07.041 Beetz, 2012, External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy, Radiother Oncol, 105, 94, 10.1016/j.radonc.2011.11.006 Christianen, 2012, Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study, Radiother Oncol, 105, 107, 10.1016/j.radonc.2011.08.009 Wopken, 2014, Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer, Radiother Oncol, 113, 95, 10.1016/j.radonc.2014.09.013 Fredriksson, 2011, Minimax optimization for handling range and setup uncertainties in proton therapy: Minimax optimization for handling uncertainties in proton therapy, Med Phys, 38, 1672, 10.1118/1.3556559 Wagenaar, 2019, Robustness evaluation using dose accumulation in head and neck IMPT, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2019.06.854 Korevaar, 2019, Practical robustness evaluation in radiotherapy – A photon and proton-proof alternative to PTV-based plan evaluation, Radiother Oncol, 141, 267, 10.1016/j.radonc.2019.08.005 Jakobi, 2015, Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis, Int J Radiat Oncol Biol Phys, 92, 1165, 10.1016/j.ijrobp.2015.04.031 Beoordeling “stand van de wetenschap en praktijk” 2015. https://www.zorginstituutnederland.nl/publicaties/rapport/2015/01/15/beoordeling-stand-van-de-wetenschap-en-praktijk. Gupta, 2019, Insurance approval for proton beam therapy and its impact on delays in treatment, Int J Radiat Oncol Biol Phys, 104, 10.1016/j.ijrobp.2018.12.021 Ning, 2019, The insurance approval process for proton radiation therapy: a significant barrier to patient care, Int J Radiat Oncol Biol Phys, 104, 10.1016/j.ijrobp.2018.12.019 Shah, 2016, Beyond a moonshot: insurance coverage for proton therapy, Lancet Oncol, 17, 559, 10.1016/S1470-2045(16)00171-6 Delaney, 2017, Using a knowledge-based planning solution to select patients for proton therapy, Radiother Oncol, 124, 263, 10.1016/j.radonc.2017.03.020 Kierkels, 2019, Automated robust proton planning using dose-volume histogram-based mimicking of the photon reference dose and reducing organ at risk dose optimization, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2018.08.023 Delaney AR, Dong L, Mascia A, Zou W, Zhang Y, Yin L, et al. Automated knowledge-based intensity-modulated proton planning: An international multicenter benchmarking study. Cancers (Basel) 2018. https://doi.org/10.3390/cancers10110420. Walsh, 2019, Decision support systems in oncology, JCO Clin Cancer Inf, 3, 1 Langendijk, 2018, Prospective data registration and clinical trials for particle therapy in Europe, Radiother Oncol, 128, 9, 10.1016/j.radonc.2018.06.001 Langendijk, 2018, Clinical trial strategies to compare protons with photons, Semin Radiat Oncol, 10.1016/j.semradonc.2017.11.008